YOU ARE HERE:
Hepatitis news
page  of 12
 
Headline
Date
  Prognosis of HIV/HCV-coinfected patients may be better than previously thought
21.06.08
  Predicting which HIV/HCV-coinfected patients will respond to HCV treatment: some expected and some surprising answers
21.06.08
  HIV and hepatitis coinfection in Africa: studies provide conflicting prevalence data
20.06.08
  Ribavirin levels after four weeks of treatment predict which HIV/hepatitis C coinfected and re-treated patients will respond
20.06.08
  HIV-positive gay men and sexual transmission of hepatitis C: it's no longer just northern Europe
20.06.08
  Around 10% of HIV-positive patients without hepatitis B virus or hepatitis C virus found to have signs of liver damage
20.06.08
  Anti-HIV treatment may mean that progression of hepatitis C no worse in coinfected patients than in those with only hepatitis C
20.06.08
  Insulin resistance means coinfected patients have a poorer response to hepatitis C treatment
19.06.08
  `Liver stiffness` and insulin resistance connection in HIV/hepatitis C coinfected patients
19.06.08
  Opt-out testing greatly expanded in new UK HIV testing guidelines, now open for consultation
11.06.08
  Higher LDL cholesterol levels mean better response to anti-HCV treatment in HIV/HCV coinfected patients
16.05.08
  HIV reduces body's ability to control hepatitis C replication
09.05.08
  Does tenofovir increase the risk of efavirenz-associated liver side-effects?
09.05.08
  BHIVA: No evidence of a hepatitis C epidemic in HIV negative gay men
28.04.08
  Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
25.04.08
  Tenofovir shows excellent promise as a treatment for hepatitis B monoinfection
25.04.08
  Patient groups campaign for better HIV/HCV treatment and care in southern Europe
08.04.08
  Revised US labelling for darunavir/ritonavir recommends caution for patients with liver problems
12.03.08
  HIV-positive gay men being infected with HCV soon after HIV; cases of HCV superinfection reported
11.03.08
  CROI: Choice of nucleoside analogue in co-infection: tenofovir associated with better response to HCV therapy
15.02.08

page  of 12